Click Therapeutics to Present at the UBS Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Wednesday, May 25, 2022 at 12:15 p.m. ET.

The UBS Global Healthcare Conference will be held May 23-25, 2022, at the Lotte New York Palace in New York City. For additional information, please visit the UBS website.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit ClickTherapeutics.com.

Contacts

Company
Daniel Busby
VP, Investor Relations & Strategic Finance
dbusby@clicktherapeutics.com